日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer

多组学分析揭示干扰素通路减弱是化疗难治性卵巢癌的驱动因素

Daria Afenteva ,Rong Yu ,Anna Rajavuori ,Marina Salvadores ,Inga-Maria Launonen ,Kari Lavikka ,Kaiyang Zhang ,Anna Pirttikoski ,Giovanni Marchi ,Sanaz Jamalzadeh ,Veli-Matti Isoviita ,Yilin Li ,Giulia Micoli ,Erdogan Pekcan Erkan ,Matias M Falco ,Daniela Ungureanu ,Alexandra Lahtinen ,Jaana Oikkonen ,Sakari Hietanen ,Anna Vähärautio ,Inderpreet Sur ,Anni Virtanen ,Anniina Färkkilä ,Johanna Hynninen ,Taru A Muranen ,Jussi Taipale ,Sampsa Hautaniemi

Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer

化疗诱导卵巢癌中髓系驱动的空间 T 细胞衰竭

Inga-Maria Launonen, Erdogan Pekcan Erkan, Iga Niemiec, Ada Junquera, María Hincapié-Otero, Daria Afenteva, Zhihan Liang, Matilda Salko, Angela Szabo, Fernando Perez-Villatoro, Matias M Falco, Yilin Li, Giulia Micoli, Ashwini Nagaraj, Ulla-Maija Haltia, Essi Kahelin, Jaana Oikkonen, Johanna Hynninen

STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer

STING 激动剂可克服卵巢癌中 STAT3 介导的免疫抑制和对 PARP 抑制的适应性抵抗

Liya Ding, Qiwei Wang #, Antons Martincuks #, Michael J Kearns, Tao Jiang, Ziying Lin, Xin Cheng, Changli Qian, Shaozhen Xie, Hye-Jung Kim, Inga-Maria Launonen, Anniina Färkkilä, Thomas M Roberts, Gordon J Freeman, Joyce F Liu, Panagiotis A Konstantinopoulos, Ursula Matulonis, Hua Yu, Jean J Zhao0

Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples

编码 CD40L 的 3 型溶瘤腺病毒促进人源化小鼠和患者样本中前列腺癌的树突状细胞治疗

Sadia Zafar, Saru Basnet, Inga-Maria Launonen, Dafne Carolina Alves Quixabeira, Joao Santos, Otto Hemminki, Minna Malmstedt, Victor Cervera-Carrascon, Pasi Aronen, Riikka Kalliokoski, Riikka Havunen, Antti Rannikko, Tuomas Mirtti, Mika Matikainen, Anna Kanerva, Akseli Hemminki